JP2010520758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010520758A5 JP2010520758A5 JP2009552983A JP2009552983A JP2010520758A5 JP 2010520758 A5 JP2010520758 A5 JP 2010520758A5 JP 2009552983 A JP2009552983 A JP 2009552983A JP 2009552983 A JP2009552983 A JP 2009552983A JP 2010520758 A5 JP2010520758 A5 JP 2010520758A5
- Authority
- JP
- Japan
- Prior art keywords
- reovirus
- nucleic acid
- residue
- polypeptide
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89442507P | 2007-03-12 | 2007-03-12 | |
| US60/894,425 | 2007-03-12 | ||
| US98956807P | 2007-11-21 | 2007-11-21 | |
| US60/989,568 | 2007-11-21 | ||
| PCT/CA2008/000483 WO2008110004A1 (en) | 2007-03-12 | 2008-03-11 | Reoviruses having modified sequences |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010520758A JP2010520758A (ja) | 2010-06-17 |
| JP2010520758A5 true JP2010520758A5 (enExample) | 2011-04-28 |
| JP5577103B2 JP5577103B2 (ja) | 2014-08-20 |
Family
ID=39758956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009552983A Active JP5577103B2 (ja) | 2007-03-12 | 2008-03-11 | 改変配列を有するレオウイルス |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US7803385B2 (enExample) |
| EP (2) | EP2132315B1 (enExample) |
| JP (1) | JP5577103B2 (enExample) |
| KR (1) | KR101647843B1 (enExample) |
| CN (1) | CN103710359A (enExample) |
| AR (1) | AR066395A1 (enExample) |
| AU (1) | AU2008226291B2 (enExample) |
| CA (1) | CA2678721C (enExample) |
| DK (1) | DK2132315T3 (enExample) |
| ES (1) | ES2548442T3 (enExample) |
| IL (4) | IL200353A (enExample) |
| MX (2) | MX2009009598A (enExample) |
| SG (1) | SG191602A1 (enExample) |
| TW (1) | TW200904979A (enExample) |
| WO (1) | WO2008110004A1 (enExample) |
| ZA (1) | ZA200905951B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
| US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
| SG191602A1 (en) | 2007-03-12 | 2013-07-31 | Oncolytics Biotech Inc | Reoviruses having modified sequences |
| JP2011500608A (ja) * | 2007-10-22 | 2011-01-06 | オンコリティクス バイオテク，インコーポレーテッド | 増殖性障害の治療レジメン |
| EP2296678A4 (en) * | 2008-05-27 | 2012-03-21 | Oncolytics Biotech Inc | MODULATION OF INTERSTITIAL PRESSURE AND ONCOLYTIC VIRUS RELIEF AND DISTRIBUTION |
| WO2009143611A1 (en) * | 2008-05-27 | 2009-12-03 | Oncolytics Biotech Inc. | Abrogating proinflammatory cytokine production during oncolytic reovirus therapy |
| BRPI0910185A2 (pt) * | 2008-06-26 | 2015-12-01 | Ceva Sante Animale S A | sorotipo de reovírus aviário isolado, reovírus aviário isolado, peptídeos, vacina, antisoro isolado, anticorpo isolado, método para proteção de aves, método para detecção ou quantificação de reovírus em aves, recipiente para vacinação de aves, kit para vacinação de aves, kit de diagnóstico, linhagem celular derivada da lmh |
| FR2939807B1 (fr) * | 2008-12-11 | 2010-12-17 | Biomerieux Sa | Nouveau reovirus isole, procedes et kits de detection |
| WO2011041789A1 (en) | 2009-10-02 | 2011-04-07 | The Trustees Of Columbia University In The City Of New York | Piscine reovirus immunogenic compositions |
| MX349294B (es) | 2010-12-02 | 2017-07-21 | Oncolytics Biotech Inc | Formulaciones virales liofilizadas. |
| EP2646051A4 (en) * | 2010-12-02 | 2014-05-28 | Oncolytics Biotech Inc | FORMULATIONS OF LIQUID VIRUSES |
| AU2012248082B2 (en) * | 2011-04-29 | 2015-08-20 | Oncolytics Biotech Inc. | Methods of purifying viruses using gel permeation chromatography |
| DK3068411T3 (da) * | 2013-11-15 | 2020-06-22 | Oncolytics Biotech Inc | Oncolytiske vira og forøget cancerbehandlingsregimer |
| US9660989B1 (en) | 2014-01-31 | 2017-05-23 | Google Inc. | Internet-wide identity management widget |
| EP3417866B1 (en) | 2016-02-16 | 2020-12-23 | Osaka University | Medicinal composition for treating fibrosis |
| WO2019237063A1 (en) * | 2018-06-07 | 2019-12-12 | Emory University | Modified reoviruses, particles, and uses in treating proliferative disorders |
| KR102401077B1 (ko) | 2019-01-25 | 2022-05-24 | 바이로큐어 주식회사 | 다람쥐 섬유종 바이러스 및 리오바이러스를 포함하는 암 예방 또는 치료용 약학적 조성물 |
| US20220193220A1 (en) * | 2019-05-03 | 2022-06-23 | Kansas State University Research Foundation | Immunogenic compositions for novel reassortant mammalian ortheovirus from pigs |
| US20240041959A1 (en) * | 2020-12-22 | 2024-02-08 | Virocure, Inc. | Novel modified reovirus and use thereof |
| CN116917468A (zh) * | 2020-12-22 | 2023-10-20 | 百洛克株式会社 | 新型修饰的呼肠孤病毒及其用途 |
| US20250154204A1 (en) * | 2021-09-24 | 2025-05-15 | Virocure, Inc. | Novel reovirus-based vaccine platform and use thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US6565831B1 (en) * | 1999-02-24 | 2003-05-20 | Oncolytics Biotech Inc. | Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| US6110461A (en) | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
| US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
| TWI289158B (en) | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
| NZ524937A (en) * | 2000-11-09 | 2004-10-29 | Oncolytics Biotech Inc | Methods for determining susceptibility of a cell to reovirus infection and for diagnosing proliferative disease treatable with reovirus |
| JP2004519431A (ja) * | 2000-12-01 | 2004-07-02 | ユニバーシティ・オブ・オタワ | 腫瘍溶解性ウイルス |
| IL157304A0 (en) | 2001-03-16 | 2004-02-19 | Oncolytics Biotech Inc | Method of extracting virus from cell culture |
| US7163678B2 (en) * | 2002-11-07 | 2007-01-16 | Oncolytics Biotech Inc. | Reovirus for the treatment of ral-mediated cellular proliferative disorders |
| WO2005111200A1 (en) * | 2004-05-17 | 2005-11-24 | Universite De Montreal | Novel strains of reoviruses and methods of uses thereof |
| WO2006001120A1 (ja) * | 2004-06-24 | 2006-01-05 | Dnavec Research Inc. | マイナス鎖rnaウイルスを含む抗癌剤 |
| US10260049B2 (en) * | 2005-08-01 | 2019-04-16 | Virocure, Inc. | Attenuated reovirus |
| WO2008009115A1 (en) | 2006-07-18 | 2008-01-24 | Ottawa Health Research Institute | Disparate suicide carrier cells for tumor targeting of promiscuous oncolytic viruses |
| SG191602A1 (en) | 2007-03-12 | 2013-07-31 | Oncolytics Biotech Inc | Reoviruses having modified sequences |
| WO2009143611A1 (en) * | 2008-05-27 | 2009-12-03 | Oncolytics Biotech Inc. | Abrogating proinflammatory cytokine production during oncolytic reovirus therapy |
| EP2646051A4 (en) * | 2010-12-02 | 2014-05-28 | Oncolytics Biotech Inc | FORMULATIONS OF LIQUID VIRUSES |
| MX349294B (es) * | 2010-12-02 | 2017-07-21 | Oncolytics Biotech Inc | Formulaciones virales liofilizadas. |
-
2008
- 2008-03-11 SG SG2013040027A patent/SG191602A1/en unknown
- 2008-03-11 CN CN201310353609.2A patent/CN103710359A/zh active Pending
- 2008-03-11 EP EP08733587.3A patent/EP2132315B1/en active Active
- 2008-03-11 MX MX2009009598A patent/MX2009009598A/es active IP Right Grant
- 2008-03-11 EP EP15176066.7A patent/EP2952583A1/en not_active Withdrawn
- 2008-03-11 DK DK08733587.3T patent/DK2132315T3/en active
- 2008-03-11 US US12/046,095 patent/US7803385B2/en active Active
- 2008-03-11 ES ES08733587.3T patent/ES2548442T3/es active Active
- 2008-03-11 KR KR1020097019418A patent/KR101647843B1/ko active Active
- 2008-03-11 JP JP2009552983A patent/JP5577103B2/ja active Active
- 2008-03-11 CA CA2678721A patent/CA2678721C/en active Active
- 2008-03-11 WO PCT/CA2008/000483 patent/WO2008110004A1/en not_active Ceased
- 2008-03-12 TW TW097108636A patent/TW200904979A/zh unknown
- 2008-03-12 AR ARP080101017A patent/AR066395A1/es unknown
- 2008-03-14 AU AU2008226291A patent/AU2008226291B2/en active Active
-
2009
- 2009-08-12 IL IL200353A patent/IL200353A/en active IP Right Grant
- 2009-08-27 ZA ZA2009/05951A patent/ZA200905951B/en unknown
- 2009-09-08 MX MX2013013938A patent/MX346950B/es unknown
-
2010
- 2010-08-02 US US12/848,684 patent/US8691241B2/en active Active
-
2012
- 2012-08-30 IL IL221701A patent/IL221701A0/en unknown
- 2012-08-30 IL IL221702A patent/IL221702A0/en unknown
- 2012-08-30 IL IL221700A patent/IL221700A0/en unknown
-
2014
- 2014-02-13 US US14/179,840 patent/US10039827B2/en active Active
-
2018
- 2018-07-03 US US16/027,206 patent/US10596260B2/en active Active
-
2020
- 2020-02-13 US US16/790,114 patent/US11246930B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010520758A5 (enExample) | ||
| JP5577103B2 (ja) | 改変配列を有するレオウイルス | |
| AU782020B2 (en) | Viruses for the treatment of cellular proliferative disorders | |
| CN102858959B (zh) | 溶瘤弹状病毒 | |
| Sinkovics et al. | Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers | |
| JP7239910B2 (ja) | 治療剤、ならびに腫瘍および／またはがんの治療のための薬物のためのその使用 | |
| WO2018058258A1 (en) | Recombinant oncolytic viruses for cancer therapy | |
| JP2010527593A (ja) | 変異レオウイルスならびにその作製および使用方法 | |
| JP7144915B2 (ja) | 腫瘍を治療するためのウイルス | |
| CN119709652A (zh) | 溶瘤病毒及其应用 | |
| AU2014292114B2 (en) | Genetically stable oncolytic RNA virus, method of manufacturing and use thereof | |
| JP7336791B2 (ja) | 腫瘍を治療するためのコクサッキーウイルスｂ群 | |
| CN101137391B (zh) | 重组高效复合干扰素的用途 | |
| WO2019141263A1 (zh) | 一种广谱抗肠道病毒的多肽及其应用 | |
| CN111714621A (zh) | 转铁蛋白、转铁蛋白受体及其抗体在制备抗SARS-CoV-2病毒的药物中的应用 | |
| EP3624825A1 (en) | Recombinant oncolytic virus | |
| WO2024207908A1 (zh) | 减毒西尼罗河病毒的疫苗、药物及应用 | |
| US20220296659A1 (en) | Pharmaceutical composition for treatment of tumor or cancer, and application thereof | |
| AU2009253683B2 (en) | Abrogating proinflammatory cytokine production during oncolytic reovirus therapy | |
| US20240318147A1 (en) | Recombinant oncolytic virus, and construction method therefor and use thereof | |
| WO2019174610A1 (zh) | 一种溶瘤病毒、合成dna序列及其应用 | |
| US20260053873A1 (en) | Combination therapy of oncolytic virus drugs for cancer treatment | |
| CN115612674B (zh) | 一种溶瘤病毒及其用途 | |
| WO2022245808A1 (en) | Oncolytic virus based cancer therapy | |
| Biotech | LOW PATHOGENIC HUMAN ENTEROVIRUSES AS NOVEL ANTI-CANCER AGENTS AGAINST MALIGNANT GLIOMA |